What's new

EMEA-002727-PIP02-23

EMEA-002727-PIP02-23

Mar 4, 2025 - 15:22
 0
EMEA-002727-PIP02-23
EMEA-002727-PIP02-23
Read More

Tags:

Previous Article

Hilton Announces Nomination of Marissa Mayer to Board of Directors, Long‑Time Di...

Next Article

Navy contractor KEEL to open new $70M facilities for submarine fabrication

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Omvoh, Mirikizumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastrointestinal disorders, PIP number: P/0534/2023

Opinion/decision on a Paediatric investigation plan (PI...

Feb 13, 2025  0

Training on human variations web-based electronic application form (eAF) functionalities for CAPs and non-CAPs variations, Online, European Medicines Agency, Amsterdam, the Netherlands, from 27 February 2025, 10:30 (CET) to 27 February 2025, 12:30 (CET)

Training on human variations web-based electronic appli...

Feb 21, 2025  0

Guideline on assessment and reporting of mechanistic models used in the context of model informed drug development

Guideline on assessment and reporting of mechanistic mo...

Feb 14, 2025  0